Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jung Hyun Chang

Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases

English

High Blood Neutrophil-Lymphocyte Ratio Associated With Poor Outcomes in Miliary Tuberculosis

Journal of Thoracic Disease

Pulmonary

Respiratory Medicine

2018

English

Related publications

Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

English

Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma After Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature

English

Successful Treatment of Non-Small Cell Lung Cancer With Gefitinib After Severe Erlotinib-Related Hepatotoxicity

Internal Medicine

Medicine

2012

English

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Journal of Experimental and Clinical Cancer Research

Cancer Research

Oncology

2008

English

The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Clinical Cancer Research

Cancer Research

Oncology

2012

English

Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation

Journal of Thoracic Oncology

English

P1.01-103 Leukocyte Telomere Length as a Novel Biomarker in Advanced Lung Adenocarcinoma Patients Treated With Gefitinib

Journal of Thoracic Oncology

English

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers With Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

Journal of Biomedicine and Biotechnology

2011

English

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jung Hyun Chang

Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma

High Blood Neutrophil-Lymphocyte Ratio Associated With Poor Outcomes in Miliary Tuberculosis

Related publications

Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma After Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature

Successful Treatment of Non-Small Cell Lung Cancer With Gefitinib After Severe Erlotinib-Related Hepatotoxicity

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation

P1.01-103 Leukocyte Telomere Length as a Novel Biomarker in Advanced Lung Adenocarcinoma Patients Treated With Gefitinib

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers With Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study